← Back to home

ADULT ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17)(Q24.1;Q21.2); PML-RARA

Clinical trials for ADULT ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17)(Q24.1;Q21.2); PML-RARA explained in plain language.

Never miss a new study

Get alerted when new ADULT ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17)(Q24.1;Q21.2); PML-RARA trials appear

Sign up with your email to follow new studies for ADULT ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17)(Q24.1;Q21.2); PML-RARA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists test Two-Pronged attack on tough blood cancers

Disease control Completed

This early-stage study tested a combination of two drugs, veliparib and temozolomide, in adults with acute leukemias that had returned or were hard to treat. The main goal was to find the highest dose patients could safely tolerate. Researchers also wanted to see if the drug comb…

Matched conditions: ADULT ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17)(Q24.1;Q21.2); PML-RARA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

ADULT ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17)(Q24.1;Q21.2); PML-RARA

Get alerted when new ADULT ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15;17)(Q24.1;Q21.2); PML-RARA trials appear

Scientists test Two-Pronged attack on tough blood cancers